Ryan Paul Neates, Finance Director at Solvonis Therapeutics, holds 3.85M shares in Solvonis Therapeutics (Ticker: GB:SVNS). Most recently, Ryan Paul Neates Bought 3,846,153 shares of Solvonis Therapeutics on May 16, 2025 for an estimated value of 5.00K.
What is the percentage of profitable transactions made by Ryan Paul Neates?
The percentage of profitable transactions made by Ryan Paul Neates is ―.
What is the average return per transaction made by Ryan Paul Neates?
The average return per transaction made by Ryan Paul Neates is ―.
What stocks does Ryan Paul Neates hold?
Ryan Paul Neates holds: GB:SVNS stocks.
What was Ryan Paul Neates’s latest transaction?
Ryan Paul Neates latest transaction was an Informative Buy of 5.00K.
What was Ryan Paul Neates's most profitable transaction?
Ryan Paul Neates’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Ryan Paul Neates's role in Solvonis Therapeutics?
Ryan Paul Neates's role in Solvonis Therapeutics is Finance Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.